Evidence map›Paper›PMID 42458322›Full record

ArticleBMC public health2026

Spatiotemporal epidemiology of hepatitis B in Central China: urbanization drivers and implications for adult-targeted control strategies.

Yanquan Mo, Shanhui Li, Ziqian Zhao, Huiqun Jia, Jingya Zhao, Feng Liu, Caixia Dang, Liyang Guo, Yuanyong Xu, Yeqing Tong and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yanquan Mo *Chinese PLA Center for Disease Control and Prevention, Beijing, China.
Shanhui Li *Chinese PLA Center for Disease Control and Prevention, Beijing, China.
Ziqian ZhaoChinese PLA Center for Disease Control and Prevention, Beijing, China.
Huiqun JiaChinese PLA Center for Disease Control and Prevention, Beijing, China.
Jingya ZhaoChinese PLA Center for Disease Control and Prevention, Beijing, China.
Feng LiuChinese PLA Center for Disease Control and Prevention, Beijing, China.
Caixia DangChinese PLA Center for Disease Control and Prevention, Beijing, China.
Liyang GuoChinese PLA Center for Disease Control and Prevention, Beijing, China.
Yuanyong XuChinese PLA Center for Disease Control and Prevention, Beijing, China. xyy_827@sina.com.
Yeqing TongDepartment of Infectious Diseases, Hubei Center for Disease Control and Prevention, Wuhan, China. t_yeqing@163.com.
Hui ChenChinese PLA Center for Disease Control and Prevention, Beijing, China. chfmmu@outlook.com.

Funding

National Key Research and Development Program 2023YFC2307500
6 · The paper itself

Abstract

backgroundHepatitis B virus (HBV) infection remains a significant global public health challenge. Hubei Province, a historically high-prevalence area in central China, continues to face persistently high rates of adult HBsAg carriers despite effective reduction of childhood transmission through universal vaccination, hindering progress toward HBV elimination goals. This study aims to identify key drivers behind the rising hepatitis B incidence in the region, forecast future trends, and inform targeted control strategies.

methodsThis population-based spatiotemporal epidemiological study analyzed hepatitis B surveillance data from Hubei Province between January 2015 and December 2024, covering 631,361 reported cases across 17 prefecture-level divisions. Spatial clustering was assessed using Global Moran's I statistics. Urbanization-related spatial drivers were identified via geographically weighted random forest modeling with SHAP value interpretation, and future incidence trends were predicted using Holt-Winters time series forecasting.

resultsThe average annual incidence was 106.19 per 100,000 population, showing a U-shaped temporal trend: declining from 111.75 per 100,000 in 2015 to 83.58 in 2020, then rising to 125.86 in 2024. Adults aged 30-50 years consistently accounted for 40-50% of total cases. Significant spatial clustering was detected (Global Moran's I: 0.124-0.307, P < 0.05), with persistent high-risk zones concentrated in the Wuhan metropolitan area. The geographically weighted random forest model identified urbanization rate as the primary spatial driver (SHAP value ≈2.0), followed by higher education enrollment rate (≈1.0) and passenger traffic volume (≈0.8). Time series forecasting projected monthly incidence rates of 8.98-10.41 per 100,000 over the subsequent 18 months (R

conclusionIn Hubei Province, the hepatitis B burden has concentrated in adults born before the vaccine era, underscoring horizontal transmission risks in this susceptible cohort. Urbanization significantly impacts the spatial distribution of hepatitis B, with high-risk areas mainly concentrated in the Wuhan metropolitan region. It is crucial to address urbanization-related factors affecting HBV transmission and to implement targeted screening and revaccination for adults aged 30-50, particularly among high-risk individuals, mobile populations, and rural residents, to reduce incidence and alleviate the regional disease burden.

Indexed as

Hepatitis BUrbanizationAdolescentAdultAgedChildChild, PreschoolChinaFemaleHumansIncidenceMaleMiddle AgedSpatio-Temporal AnalysisYoung AdultCentral ChinaGeographically Weighted Random Forest ModelHepatitis BSHapley Additive exPlanationsUrbanization

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.